Addressing Knowledge Gaps in Diagnosing and Managing Inborn Errors of Immunity,
Role: PD/PI,
The Allergists' Foundation,
(08/2024 - 07/2025)
Status: Awarded
Internal
The prevalence of exercise-induced bronchoconstriction (EIB) among young adults in Southern California,
Role: Investigator,
LLU Dept. of Medicine,
(05/2020)
Status: Approved
Compassionate Use of CDZ173 (LENIOLISIB),
Role: PI,
LLU Dept. of Pediatrics,
Status: Completed
Other Research
"Addressing Knowledge Gaps in Diagnosing and Managing Inborn Errors of Immunity" Planning Grant from the Allergist's Foundation Community Grant Program from the American College of Allergy, Asthma and Immunology, 2024 Community Grant Recipient
(08/2024 - 08/2025)
IRB Approved. HS 5190425. PI. Compassionate use of CDZ173 (Leniolisib)
PI for compassionate use of Leniolizib- PI3Kinase inhibitor for patient with severe immunodeficiency with PASLI and CNS lesions.
(12/2019 - 03/2023)